Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapeutic medicines for unmet needs.
Tavotek Biotherapeutics has raised $55.0M across 2 funding rounds.
Tavotek Biotherapeutics has raised $55.0M in total across 2 funding rounds.
Tavotek Biotherapeutics has raised $55.0M in total across 2 funding rounds.
Tavotek Biotherapeutics's investors include CS Capital, Fontus Capital, CTS Capital, Lanhu Capital, New Alliance Capital, Oriza Holdings.
Tavotek Biotherapeutics has raised $55.0M across 2 funding rounds. Most recently, it raised $35.0M Series B in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 20, 2021 | $35.0M Series B | CS Capital | Fontus Capital |
| Mar 22, 2021 | $20.0M Series A | CTS Capital, Lanhu Capital, New Alliance Capital, Oriza Holdings |